Remove Life Science Remove Medicine Remove Pharma Companies
article thumbnail

Cloud robotics labs are accelerating drug discovery and development

Pharmaceutical Technology

Considering the low chances of success, with only 10% of drug candidates making it into clinical development, pharma companies must prevent the increased erosion of profit margins. For example, AstraZeneca is automating the enter design-make-test-analyse cycle for drug discovery in its Swedish iLab. Remote-controlled robotic labs.

article thumbnail

Reaching New Global ‘Frontiers’ In Life Sciences

Intouch Solutions

The annual event assembled nearly 1,000 attendees from over 40+ countries across the healthcare ecosystem to learn, network and explore industry challenges, strategic trends and solutions in life sciences and healthcare.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Life Science Trends to Look Out for in 2024

XTalks

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables.

article thumbnail

Top 10 Most Environmentally Sustainable Pharma Companies in 2023/2024

XTalks

There was also significant variability in emissions, up to five times, between pharma companies with comparable revenues. For example, Proctor & Gamble was found to emit almost five times more CO 2 e than Johnson & Johnson despite the two companies having similar revenue levels and producing similar lines of products.

article thumbnail

Key Trends in the Life Sciences to Look Forward to in 2022

XTalks

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. Here is a look at some life science trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.

article thumbnail

Jupiter Neurosciences Makes Way in CNS Treatments with $11M IPO

XTalks

Jupiter Neurosciences, a clinical-stage pharma company specializing in neuroinflammation, made its public market debut with an initial public offering (IPO) on the Nasdaq Capital Market under the symbol “JUNS.” ” The company priced 2,750,000 shares of common stock at $4.00

article thumbnail

The largest pharma company in Europe calls for interoperability

pharmaphorum

EHDS is the first data space devised to promote health-data exchange and support research on new treatments, preventative strategies, medicines, and medical devices while aiming to allow individuals the right to control their personal health data. The post The largest pharma company in Europe calls for interoperability appeared first on.